Fineline Cube

Follow:
14486 Articles
Bristol-Myers Squibb's Opdivo-Yervoy Combo Nears FDA Approval for MSI-H Colorectal Cancer
CompanyDrug

Bristol-Myers Squibb’s Opdivo-Yervoy Combo Nears FDA Approval for MSI-H Colorectal Cancer

CanSino Biologics Receives NMPA Approval for DTcP Hib MCV4 Combined Vaccine
CompanyDrug

CanSino Biologics Receives NMPA Approval for DTcP Hib MCV4 Combined Vaccine

MGI Tech Partners with Oncoclínicas&Co to Advance Precision Medicine in Brazil
CompanyDeals

MGI Tech Partners with Oncoclínicas&Co to Advance Precision Medicine in Brazil

Boehringer Ingelheim's Nerandomilast Receives NMPA Review for IPF Treatment
CompanyDrug

Boehringer Ingelheim’s Nerandomilast Receives NMPA Review for IPF Treatment

QYuns Therapeutics' QX002N Meets Primary Endpoint in AS Phase III Study
CompanyDrug

QYuns Therapeutics’ QX002N Meets Primary Endpoint in AS Phase III Study

Takeda's Takhzyro Receives EMA Approval for New Administration Form in HAE Patients
CompanyDrug

Takeda’s Takhzyro Receives EMA Approval for New Administration Form in HAE Patients

National Allied Procurement Office Allows VBP Winners to Adjust MAH and Manufacturing Details
Policy / Regulatory

National Allied Procurement Office Allows VBP Winners to Adjust MAH and Manufacturing Details

Ipsen Posts 8.7% Revenue Growth in 2024, Driven by Rare Diseases and Oncology
Company

Ipsen Posts 8.7% Revenue Growth in 2024, Driven by Rare Diseases and Oncology

Meyer FSMP Hong Kong Secures NMPA Approval for First FSMP in Greater China
CompanyDrug

Meyer FSMP Hong Kong Secures NMPA Approval for First FSMP in Greater China

Pfizer Halts Global Development of Hemophilia B Gene Therapy Beqvez Amid Limited Demand
CompanyDeals

Pfizer Halts Global Development of Hemophilia B Gene Therapy Beqvez Amid Limited Demand

Jointown Pharmaceutical Partners with Shandong DYNE to Boost Pediatric Drug Distribution
CompanyDeals

Jointown Pharmaceutical Partners with Shandong DYNE to Boost Pediatric Drug Distribution

CSPC Pharmaceutical Initiates Phase III Trial for Ammuxetine in Depression Treatment
CompanyDrug

CSPC Pharmaceutical Initiates Phase III Trial for Ammuxetine in Depression Treatment